Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.28.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.28.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.28.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.28.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GA.6.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15159.2France
GA.6.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GA.6.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GA.6.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.61ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.61ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.61ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.61NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FR.1.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FR.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FR.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FR.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.2.2.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.2.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-16900.3China
FL.2.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.2.2.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.25ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-802.098France
FL.25ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.25ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
FL.25NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.33ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.33ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.33ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.33NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.29ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.29ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.29ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.29NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.13ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.13NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GP.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GP.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GP.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
GP.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HL.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HL.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HL.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HL.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XCDORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XCDENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XCDENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XCDNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.44.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.44.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used